Introduction
Human T-lymphotropic virus type I (HTLV-I) is thought to be the causative agent not only of adult Tcell leukemia (ATL) [1] but also of HTLV-I-associated myelopathy (HAM/TSP) [2] , HTLV-I-associated arthropathy (HAAP) [3] , and HTLV-I uveitis [4] . Several studies have revealed that HTLV-I causes immunologic abnormalities in vitro [5] [6] [7] [8] . Based on these findings, HTLV-I-associated syndrome, which includes these immune-mediated diseases, has been proposed. There are several reports of experimental models of the HTLV-I-associated syndrome [9, 10] , and we previously have reported HTLV-I uveitis in a rabbit [11] . There have been no reports of the establishment of an HTLV-I-infected T-cell line or clone from anterior chamber infiltrating cells of HTLV-I uveitis patients. We established a T-cell clone from the cells in the anterior aqueous chamber of the eye for the first time, and a T-cell line from the peripheral blood lymphocytes of this rabbit. We also found the existence of antigenic crossreactivity between HTLV-I and retinal antigens recognized by T cells [12] , and we postulated that as HTLV-Iinfected cells have more HTLV-I antigens, the immune system can recognize and respond to HTLV-I-infected cells and these responses lead to the expansion of autoreactive T cells against retina and to uveitis. Therefore, in an effort to ascertain the relationship between HTLV-I-infected cell lines and uveitis, we examined viral production in these cell lines.
Materials and methods

HTLV-I uveitis model
One rabbit developed bilateral uveitis 3.5 years after transfusion of 10 ml peripheral blood from an HTLV-I-infected rabbit [11] . Uveitis was diagnosed by histopathologic examination.
Cell lines
Two HTLV-I-infected cell lines were established. One, from the peripheral blood, was named UV-2, while the other, from the anterior chamber of the eye, was named UV-1. They were generated by co-cultivation with normal rabbit peripheral blood lymphocytes which were attenuated by irradiation (10000 rad). Other HTLV-I-infected cell lines included the human T-cell line MT-2 [13] , the rabbit T cell line Ra-1 [14] , Melanesian ATL [15] , and the peripheral blood lymphocytes of an HTLV-I carrier patient (MN). All cell lines were cultured in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum (FCS; ICN Biomedicals Japan, Osaka) and 5x 10-SM 2-mercaptoethanol (2-ME) in the presence of 50 IU/ml interleukin-2 (IL-2) (Takeda, Osaka).
Generation of RAC-1 as the T-cell clone of UV-1 T-cell cloning was accomplished by limiting dilution [16] . Briefly, UV-1 cells were plated at a density of 0.3 cells/well and cultured on a 96-well flat-bottomed microplate (Nunc, Roskilde, Denmark) in 200 pl of RPMI 1640 containing 10% FCS, 5 x 10 5 M 2-ME, and 50 IU/ml IL-2. Two weeks later, two T-cell sublines were established. The same manipulation was repeated, and one clone was established and designated RAC-1.
Detection of proviral DNA integrated in cellular DNA
More than 107 RAC-1 cells, MT-2 cells, and MN cells were used to prepare cellular DNA. High-molecular-weight DNA was extracted by treating the cells overnight with sodium dodecyl sulfate/proteinase K, followed by phenol extraction. Then cellular DNA was digested with EcoRI or PstI and the digest was separated by electrophoresis in an agarose gel. The DNAs in the gel were blotted onto a nitrocellulose filter and hybridized with cloned viral DNAs (lambda-HTLV-I) using standard conditions. The filter was washed several times at 65 ° C and then was exposed to X-ray film at -7 0 ° C. analysis was performed in an EPICS 752 (Coulter Electronics, Hialeah, Fla.).
Reverse transcriptase assay
The number of released virus particles was estimated by the detection of reverse transcriptase (RNA-dependent DNA polymerase) activity in each cultured cell medium [20] . A quantity of 12 ml of each culture medium, harvested when the cells reached a concentration of 1 x 106 cells/ml, was centrifugated at 7200 g for 10 rain and the supernatant was then centrifugated at 120000 g for 3 h at 4 ° C. The pellet was resuspended in 50 ~tl of 50 mM Tris-HC1 (pH 7.8). Reverse transcriptase activity in 25 gl of the virus suspension was assayed in a standard reaction mixture (100 gl) containing 50 mM Tris-HC1 (pH 7.8), 60 mM KC1, 0.05 mM MnC12, 2 mM dithiothreitol, 0.05% Triton X-100, 0.4 A260 unit poly(A) oligo(dT), and 5 pCi of 3H-labeled 2'-deoxythymidine 5'-triphosphate (TTP; Amersham, Tokyo, Japan; 116 Ci/mmol) followed by 1 h incubation at 37 ° C. The acid precipitable counts were measured using a liquid scintillation analyzer.
Quantification of intracellular HTLV-I antigens
Cell pellets were made as above. Their cell membranes were destroyed by 0.2% deoxycholic acid sodium, and then supercentrifugated (30000 rpm, 90 minutes). After centrifugation, the supernatants were collected and named "HTLV-I antigen fluid". The amount of HTLV-I antigen in this fluid was measured by the antigen competition method using a commercially available enzyme-linked immunosorbent assay kit (Eitest-ATL, EISAI, Tokyo).
Results
Southern blot analysis
The cellular D N A samples were digested with EcoRI, which does not cut the HTLV-I proviral genome. In this Cell surface markers and viral antigens A monoclonal antibody to rabbit T cells (Lll/135) [17] and rabbit Ia (MHC class II) antigen (2C4) [18] were used for the flow-cytometric analysis. HTLV-I antigens were examined by fixed-cell indirect immunofluorescence using a reference serum from a patient with ATL and monoclonal antibodies to HTLV-I p19 and p24 [19] .
Flow-cytometric analysis RAC-1 cells were incubated with the appropriate dilutions of the first antibodies (anti-rabbit T cell and anti-rabbit Ia) for 30 min on ice and washed once with PBS containing 1% FCS. The cells were incubated further with FITC-conjugated second antibody for 30 min on ice. The ceils were washed once, and flow-cytometric assay, any provirus DNA sequence which integrated at a single chromosomal location was detected as a discrete band, but sequences which integrated into multiple sites would yield multiple bands [21] . As shown in Fig. 1 , the HTLV-I proviral genome inserted in RAC-1 at only one site, whereas in MT-2 and MN it had many insertion sites.
Flow-cytometric analysis
More than half of RAC-1 cells were positive for anti-Tcell marker and anti-Ia (Fig. 2) .
Reverse transcriptase assay
As shown in Fig. 3 , in experiments 1 and 2 the incorporation of [~H]-TTP in RAC-1 and UV-2 cells was about three times greater than in the other HTLV-I infected cell lines tested.
Quantification of intracellular HTLV-I antigens
In order for the HTLV-I antigen fluid of MT-2 and RAC-1 to yield an equivalent absorbance (at 405 nm), the HTLV-I antigen fluid of RAC-1 had to be diluted threefold more, implying that RAC-1 cells had about three times more HTLV-I protein antigen than did MT-2 (Fig. 4) . 
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Discussion
There have been reports that HTLV-I causes autoimmune diseases such as myelopathy, arthropathy, and uveitis. Several studies [22, 23] suggest that T cells are involved in the etiology of uveitis. We also reported the possibility that CD4-positive T cells play a role in HTLV-I uveitis [12] . These reports led us to investigate the part played in the generation of uveitis by HTLV-Iinfected cells, that have infiltrated into the anterior chamber.
We have established an HTLV-I-infected T-cell clone (RAC-1) from anterior chamber infiltrated cells of an HTLV-I uveitis animal model for the first time and have characterized it. This T-cell clone can produce HTLV-I viruses as demonstrated by reverse transcriptase assay and quantification of intracellular virus antigen. This clone was able to produce greater quantities of HTLV-I virus than any other HTLV-I-infected cell lines tested.
Ia (MHC class II) molecules are thought to be surface markers for activated T cells [24] , and RAC-1 cells had Ia molecules on their surface. This suggests that they were activated. In inflammatory diseases, especially those thought to be caused by immunologic agents, the proportion of Ia-positive T cells in peripheral blood lymphocytes increases [24] . Even though HTLV-I-infected cells were generally Ia positive, and Ia positivity is not unique to RAC-1, there may be some relationship between RAC-1 and the generation of uveitis in this model.
For the reverse transcriptase assay, virus particles in the culture medium were used, so that we only evaluated the quantity of secreted HTLV-1 virus particles from cells. Furthermore, these types of assays do not always parallel in vivo results. The reverse transcriptase assay data suggest that RAC-1 and UV-2, which were derived from an HTLV-I uveitis rabbit, can excrete three times more virus particles than other HTLV-I-infected cell lines tested.
As well as excreting HTLV-I antigens to extracellular spaces, RAC-1 cells had more HTLV-1 antigen proteins in their intracellular spaces than did MT-2 cells.
We consider that the high viral production of RAC-1 led to a breakdown in the immune balance because of the expression of much foreign antigen to the immune system in vivo, so that RAC-1 cells were recognized by the immune system, thus leading to uveitis. Whether cells which produce large quantity of the virus are responsible for the immunologic response associated with HTLV-I infection remains to be proven.
To confirm the relationship between RAC-1 and uveitis, we believe that it is important to transfer the RAC-1 cells into rabbits and observe whether or not the animals develop uveitis. Such experiments are in progress.
Another important area of research is the level of cytokine synthesis by these cell lines [25] , because there may be a direct relationship between such cytokine synthesis and uveitis. Cytokines such as interleukin-1 and tumor necrosis factor can augment inflammation and damage tissues directly. Experiments which should help clarify the mechanism of uveitis in this animal model are also underway.
